0001209191-20-061669.txt : 20201203
0001209191-20-061669.hdr.sgml : 20201203
20201203192358
ACCESSION NUMBER: 0001209191-20-061669
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201201
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Richard
CENTRAL INDEX KEY: 0001779787
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38943
FILM NUMBER: 201368185
MAIL ADDRESS:
STREET 1: C/O PERSONALIS, INC.
STREET 2: 1330 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Personalis, Inc.
CENTRAL INDEX KEY: 0001527753
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 275411038
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-752-1300
MAIL ADDRESS:
STREET 1: 1330 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-01
0
0001527753
Personalis, Inc.
PSNL
0001779787
Chen Richard
C/O PERSONALIS, INC.
1330 O'BRIEN DRIVE
MENLO PARK
CA
94025
0
1
0
0
Chief Scientific Officer
Common Stock
2020-12-01
4
M
0
40000
0.44
A
152750
D
Common Stock
2020-12-01
4
S
0
14388
27.75
D
138362
D
Common Stock
2020-12-01
4
S
0
25612
28.14
D
112750
D
Common Stock
2020-12-02
4
S
0
293
27.76
D
112457
D
Stock Option (Right to Buy)
0.44
2020-12-01
4
M
0
40000
0.00
D
2022-03-07
Common Stock
40000
31884
D
Stock Option (Right to Buy)
28.17
2020-12-01
4
A
0
30000
0.00
A
2030-12-01
Common Stock
30000
30000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $27.75, and the range of prices were between $27.02 and $28.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $28.14, and the range of prices were between $28.025 and $28.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Shares sold to cover tax obligation from settlement of vested restricted stock units.
The shares subject to the option are fully vested and exercisable.
The shares subject to the option vest in 12 equal monthly installments starting on April 16, 2023.
/s/ Aaron Tachibana, Attorney-in-Fact
2020-12-03